ARCHIVES

NCI says SELECT study is close to full enrollment.

This article is from The Cancer Letter archive.

Vol. 30 No. 17 | April 23, 2004

Download PDF Visit The Full Archive

Related Articles

Review Of NTP Could Lead To Administrative Changes

April 18, 1980

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

In Brief: Pediatric Groups Endorse Merger Plan; NCI Charters Consumer Liaison Group

November 13, 1998

Researchers Link Obesity With 34% Higher Death Risk In Pre-Menopausal Women

May 30, 2014